DK131474B - Analogifremgangsmåde til fremstilling af 9alfa-halogen-11beta, 17alfa, 21-trihydroxy-16beta-metylpregna-1,4-dien-3,20-dion-21-adamantan-1'-karboxylater. - Google Patents
Analogifremgangsmåde til fremstilling af 9alfa-halogen-11beta, 17alfa, 21-trihydroxy-16beta-metylpregna-1,4-dien-3,20-dion-21-adamantan-1'-karboxylater.Info
- Publication number
- DK131474B DK131474B DK331372AA DK331372A DK131474B DK 131474 B DK131474 B DK 131474B DK 331372A A DK331372A A DK 331372AA DK 331372 A DK331372 A DK 331372A DK 131474 B DK131474 B DK 131474B
- Authority
- DK
- Denmark
- Prior art keywords
- 16beta
- 9alpha
- methylpregna
- 11beta
- 17alpha
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3134971A GB1391443A (en) | 1971-07-05 | 1971-07-05 | Ester of betamethasone and its 9alpha-chloro analogue |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK131474B true DK131474B (da) | 1975-07-21 |
| DK131474C DK131474C (fr) | 1975-12-08 |
Family
ID=10321802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK331372AA DK131474B (da) | 1971-07-05 | 1972-07-04 | Analogifremgangsmåde til fremstilling af 9alfa-halogen-11beta, 17alfa, 21-trihydroxy-16beta-metylpregna-1,4-dien-3,20-dion-21-adamantan-1'-karboxylater. |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS5644079B1 (fr) |
| AR (2) | AR194120A1 (fr) |
| AU (1) | AU464251B2 (fr) |
| BE (1) | BE785812A (fr) |
| CA (1) | CA983919A (fr) |
| CH (1) | CH609065A5 (fr) |
| DE (1) | DE2232827A1 (fr) |
| DK (1) | DK131474B (fr) |
| FR (1) | FR2144761B1 (fr) |
| GB (1) | GB1391443A (fr) |
| IE (1) | IE36529B1 (fr) |
| IL (1) | IL39821A (fr) |
| NL (1) | NL169882C (fr) |
| NO (1) | NO137754C (fr) |
| PH (1) | PH13195A (fr) |
| SE (1) | SE385904B (fr) |
| ZA (1) | ZA724598B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5024427A (fr) * | 1973-01-03 | 1975-03-15 | ||
| SE418294B (sv) * | 1974-03-27 | 1981-05-18 | Plurichemie Anstalt | Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester |
| JPS6163976U (fr) * | 1984-10-01 | 1986-05-01 | ||
| KR101591482B1 (ko) | 2008-05-28 | 2016-02-03 | 레베라겐 바이오파마 인코포레이티드 | 질환의 치료를 위한 ＮＦ-κＢ 의 비호르몬성 스테로이드 조절제 |
| EP2556083A4 (fr) | 2010-04-05 | 2013-12-04 | Validus Biopharma Inc | Modulateurs stéroïdes non hormonaux de nf- kappa b pour le traitement de maladies |
| US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
| US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
-
0
- BE BE785812D patent/BE785812A/fr not_active IP Right Cessation
-
1971
- 1971-07-05 GB GB3134971A patent/GB1391443A/en not_active Expired
-
1972
- 1972-07-04 CH CH1003472A patent/CH609065A5/xx not_active IP Right Cessation
- 1972-07-04 ZA ZA724598A patent/ZA724598B/xx unknown
- 1972-07-04 NL NLAANVRAGE7209345,A patent/NL169882C/xx not_active IP Right Cessation
- 1972-07-04 AU AU44205/72A patent/AU464251B2/en not_active Expired
- 1972-07-04 NO NO2406/72A patent/NO137754C/no unknown
- 1972-07-04 FR FR7224132A patent/FR2144761B1/fr not_active Expired
- 1972-07-04 IL IL39821A patent/IL39821A/xx unknown
- 1972-07-04 JP JP6640472A patent/JPS5644079B1/ja active Pending
- 1972-07-04 CA CA146,248A patent/CA983919A/en not_active Expired
- 1972-07-04 IE IE939/72A patent/IE36529B1/xx unknown
- 1972-07-04 SE SE7208817A patent/SE385904B/xx unknown
- 1972-07-04 DE DE2232827A patent/DE2232827A1/de not_active Ceased
- 1972-07-04 AR AR242889A patent/AR194120A1/es active
- 1972-07-04 DK DK331372AA patent/DK131474B/da unknown
- 1972-07-05 PH PH13687A patent/PH13195A/en unknown
-
1973
- 1973-05-21 AR AR248131A patent/AR194553A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| IL39821A (en) | 1976-02-29 |
| IE36529B1 (en) | 1976-11-24 |
| FR2144761B1 (fr) | 1976-03-05 |
| FR2144761A1 (fr) | 1973-02-16 |
| SE385904B (sv) | 1976-07-26 |
| BE785812A (fr) | 1973-01-04 |
| NL169882B (nl) | 1982-04-01 |
| AU4420572A (en) | 1974-01-10 |
| DE2232827A1 (de) | 1973-01-18 |
| AR194120A1 (es) | 1973-06-22 |
| NL7209345A (fr) | 1973-01-09 |
| JPS5644079B1 (fr) | 1981-10-16 |
| ZA724598B (en) | 1973-03-28 |
| AR194553A1 (es) | 1973-07-23 |
| IL39821A0 (en) | 1972-09-28 |
| NO137754B (no) | 1978-01-09 |
| DK131474C (fr) | 1975-12-08 |
| IE36529L (en) | 1973-01-05 |
| GB1391443A (en) | 1975-04-23 |
| CA983919A (en) | 1976-02-17 |
| NL169882C (nl) | 1982-09-01 |
| PH13195A (en) | 1980-01-18 |
| NO137754C (no) | 1978-04-19 |
| AU464251B2 (en) | 1975-08-21 |
| CH609065A5 (en) | 1979-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK134783B (da) | Analogifremgangsmåde til fremstilling af 16alfa,17alfa-alkylidendioxypregna-1,4-dien-11beta,21-diol-3,20-dioner. | |
| DK135047B (da) | Analogifremgangsmåde til fremstilling af 11,11-alkylidensteroider af estran- eller 19-norpregnanrækken. | |
| DK136075B (da) | Analogifremgangsmåde til fremstilling af 11beta-hydroxy-16-methyl-3-oxo-17alfa-acyloxyandrosta-1,4,15-trien-17beta-carboxylater. | |
| DK136534C (da) | Analogifremgangsmade til fremstilling af d-homopregna-1,4-dien-3,20-dioner | |
| DK131474B (da) | Analogifremgangsmåde til fremstilling af 9alfa-halogen-11beta, 17alfa, 21-trihydroxy-16beta-metylpregna-1,4-dien-3,20-dion-21-adamantan-1'-karboxylater. | |
| DK135722B (da) | Analogifremgangsmåde til fremstilling af 11beta,17aalfa,21-trihydroxy-D-homopregn-4-en-3,20-dioner. | |
| DK128352B (da) | Analogifremgangsmåde til fremstilling af 9α-fluor-11β-hydroxypregna-1,4-dien-3,20-dion-[17α,16α-d]-oxazolidinoxaziner. | |
| DK134816B (da) | Analogifremgangsmåde til fremstilling af estre af 11beta, 17alfa, 21-trihydroxy-16beta-methylpregna-1,4,8-trien-3,20-dion. | |
| DK129039B (da) | Fremgangsmåde til fremstilling af 11β,16α17α21-tetrahydroxy-pregna-1,4-dien-3,20-dioner eller de tilsvarende 16,17-acetonider. | |
| DK131036B (da) | Analogifremgangsmåde til fremstilling af 3,16alfa,17xi-trihydroxy-11beta-alkoxyestra-1,3,5(10)-triener. | |
| DK135167B (da) | Analogifremgangsmåde til fremstilling af 7,7'-ditheophyllinderivater. | |
| DK133382B (da) | Analogifremgangsmåde til fremstilling af 6alfa,9alfa-diflour-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-dien-3,20-dion-17,21-diacetat. | |
| DK140728B (da) | Fremgangsmåde til fremstilling af pregnanderivater. | |
| DK128738B (da) | Analogifremgangsmåde til fremstilling af cardenolid- eller bufadienolid-3-[2',3'-didesoxyglycosider]. | |
| DK122454B (da) | Fremgangsmåde til fremstilling af 9α,21,21-triklor-11β-fluor-pregn-4-en-3,20-dioner. | |
| DK130957B (da) | Fremgangsmåde til fremstilling af pregnanderivater. | |
| DK127778B (da) | Fremgangsmåde til fremstilling af 3',4'-dideoxy-kenamycin B. | |
| DK132221B (da) | Fremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimider. | |
| DK139586B (da) | Analogifremgangsmåde til fremstilling af 2,2-dimethyl-19-nor-pregn-4-en-3,20-dioner. | |
| DK128736B (da) | Analogifremgangsmåde til fremstilling af 3,17β-dialkoxy-estra-1,3,5(10)-triener. | |
| DK140847B (da) | Analogifremgangsmåde til fremstilling af 2,2-dimethyl-pregn-4-en-3,20-dioner. | |
| DK140313B (da) | Analogifremgangsmåde til fremstilling af 1-sulfonyl-5(6)-substitueret-benzimidazoler. | |
| DK136829B (da) | Analogifremgangsmåde til fremstilling af 17beta-C1-8-alkoxy-3'H-cyclopropa(16alfa,17alfa)5alfa-androstano(2,3-d)isoxazoler. | |
| DK134700B (da) | Analogifremgangsmåde til fremstilling af 21-alkylerede 16alfa,17alfa-alkylidendioxy-pregn-4-en-3,20-dioner. | |
| DK129345B (da) | Analogifremgangsmåde til fremstilling af 22-fluor-3'''-acyldigoxiner. |